|
CHD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.80850906367414E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74979997158431E-09 |
| Normal-vs-Stage2 |
3.71929999998244E-06 |
| Normal-vs-Stage3 |
1.82629467104789E-11 |
| Normal-vs-Stage4 |
2.05010453058208E-11 |
| Stage1-vs-Stage2 |
8.926800E-01 |
| Stage1-vs-Stage3 |
4.281600E-02 |
| Stage1-vs-Stage4 |
4.004000E-03 |
| Stage2-vs-Stage3 |
2.076600E-01 |
| Stage2-vs-Stage4 |
5.608100E-02 |
| Stage3-vs-Stage4 |
3.857800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.08852984590658E-12 |
| Normal-vs-AfricanAmerican |
3.280700E-03 |
| Normal-vs-Asian |
2.44860000053748E-07 |
| Caucasian-vs-AfricanAmerican |
2.171000E-01 |
| Caucasian-vs-Asian |
9.013400E-01 |
| AfricanAmerican-vs-Asian |
3.041000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.16639997660428E-09 |
| Normal-vs-Female |
1.09230402500771E-11 |
| Male-vs-Female |
7.719800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.92080004626882E-09 |
| Normal-vs-Age(41-60Yrs) |
2.31289998264828E-09 |
| Normal-vs-Age(61-80Yrs) |
3.48450157616753E-11 |
| Normal-vs-Age(81-100Yrs) |
2.638700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.978800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.758200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.790800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.601370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.205200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.037200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.403830E-04 |
| Classical-VS-Follicular |
3.496600E-01 |
| Classical-VS-Other |
5.046600E-01 |
| Classical-VS-Normal |
2.96080049366765E-10 |
| Tall-VS-Follicular |
2.952100E-02 |
| Tall-VS-Other |
1.513560E-01 |
| Tall-VS-Normal |
1.1086020990092E-11 |
| Follicular-VS-Other |
4.117600E-01 |
| Follicular-VS-Normal |
1.84040000017482E-07 |
| Other-VS-Normal |
1.042370E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.5613999810048E-10 |
| Normal-vs-N1 |
2.32410000133854E-08 |
| N0-vs-N1 |
5.499000E-01 |
|
|
